Notification and current-status evidence
The sent-report ledger records the first outgoing report at . A report was sent to the recorded registrar; contact details remain in Domain Intelligence. The latest stored availability evidence still shows the domain reachable; 5 months has elapsed since the first outgoing report.
ICANN RAA §3.18 describes registrar abuse-contact and handling obligations. This section records outgoing timestamps and later availability. It does not by itself prove receipt, acknowledgement, investigation, remediation, or contractual non-compliance.
purepharmas[.]com
“Research-Grade Peptides”
Resumo das evidências
The domain purepharmas.com was registered on March 11, 2026 and is hosted on IP 193.23.118.89, which belongs to ASN AS214036 (Ultahost, Inc.) and resolves to the Netherlands. The authoritative nameservers are elliott.ns.cloudflare.com and may.ns.cloudflare.com, and the site presents a valid Let’s Encrypt R13 TLS certificate. The landing page returns HTTP 200 and carries the title “Research-Grade Peptides,” suggesting a fabricated pharmaceutical front.
Infrastructure analysis shows a WordPress stack backed by MySQL, PHP, Yoast SEO, Apache HTTP Server, Underscore.js, Swiper, and reCAPTCHA. An MX record for mail.purepharmas.com is present with priority 0, indicating a functional mail subsystem. The domain’s Gridinsoft trust score is 0 / 100, and VirusTotal reports a single vendor detection out of 95 scanners. The domain appears on one external blocklist and is already listed by PhishDestroy as malicious.
Threat assessment identifies a high‑risk brand‑impersonation campaign targeting the “compound” brand, with the profile labeled as a cryptocurrency scam. The site’s content and language are crafted to lure victims into purchasing purported research‑grade peptides, likely to harvest cryptocurrency payments. While the exact payment mechanisms are not visible in the current snapshot, the presence of reCAPTCHA and a legitimate TLS certificate suggests an attempt to appear trustworthy and evade automated detection.
Defenders should immediately block purepharmas.com at DNS and proxy layers, enforce email filtering for the associated MX host, and monitor for any outbound connections to the 193.23.118.89 address. Continuous scanning of related Cloudflare‑served subdomains is advised, as is the deployment of sinkhole redirects for any future resolution attempts. Given the active status and high risk rating, organizations should also alert users about the fraudulent “Research‑Grade Peptides” offering and reinforce policies against unsolicited cryptocurrency payment requests.
Instantâneo das evidências enviadas
- Enviado
- Registros do livro-razão
- 1
- ID do caso
PD-20260311-F97AB5- Título da página capturada
- Research-Grade Peptides & High-Purity Research Compounds
- Artefato PDF
- Evidência em PDF
Base jurídica
Texto completo da evidência
Illegal Activities: Active phishing operation targeting victims
Fraud & Deception: Impersonation of legitimate services
Identity Theft: Collection of credentials under false pretenses
Applicable Laws (IS):
International Anti-Cybercrime Regulations
Budapest Convention on Cybercrime
Universal Fraud Prevention Laws
Phishing activities violate international cybercrime conventions and IS's domestic fraud laws.
Action Required: This evidence-backed report demonstrates clear violations requiring suspension per your policies. Continued hosting exposes your organization to regulatory scrutiny and potential legal liability.
Data Coverage
Inteligência de segurança de rede
| Detection System | Indicator | Verdict | Alert |
|---|---|---|---|
| DNS4EU | purepharmas.com |
malicious | Sinkholed |
Pipeline de resposta a ameaças
Cobertura de listas de bloqueio
10 fontes externas monitoradas · instantâneo de 12/08/2026
10 fontes externas monitoradas Sem correspondência
Linha do tempo de detecção
-
VirusTotal
0 → 1
Captura armazenada
Inteligência de Domínios
Detalhes técnicosDNS, nomes TLS e datas
ICANN OVERSIGHT
Credenciamento e contexto RAA
Credenciamento e contexto RAA
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Análise do VirusTotal
Análise de desempenho do site
Google PageSpeed Insights — mobile performance audit of purepharmas.com · checked Mar 11, 2026
Você foi afetado por este site?
Se você inseriu credenciais de conta, informações pessoais ou de pagamento, ou baixou um arquivo deste domínio, tome medidas imediatas. Abaixo estão os recursos para ajudá-lo a relatar o incidente e se proteger.
Notifique as autoridades locais
Selecione seu país para obter contactos oficiais do cibercrime ou crie um rascunho de reclamação →.
Verificar qualquer domínio
Análise de ameaças usando lista de bloqueio armazenada, WHOIS, DNS e evidências de verificação pública
Digitalize agoraDenunciar phishing
Envie domínios suspeitos para nosso banco de dados de ameaças — proteja a comunidade
DenunciarFeed de ameaças em tempo real
Relatórios recentes de phishing e alterações de disponibilidade observadas
MonitorarMantenha-se informado, mantenha-se seguro
Monitore ameaças em tempo real ou conteste esta listagem caso acredite que se trate de um falso positivo